Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components
- PMID: 9609406
- DOI: 10.1007/s001340050571
Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components
Abstract
Objective: To determine the concentration of proteins and phospholipids, markers of inflammatory reaction such as platelet-activating factor (PAF), and cell alterations in bronchoalveolar lavage (BAL) fluid during the evolution of the acute respiratory distress syndrome (ARDS).
Design: Prospective controlled study.
Setting: 14-bed medical-surgical intensive care unit in a 750-bed university teaching hospital.
Patients: 19 mechanically ventilated patients, 9 patients with ARDS and 10 patients without cardiopulmonary disease (controls), were eligible for this study.
Interventions: BAL was performed during the early, intermediate, and late phases of ARDS.
Measurements and results: Total phospholipids and individual phospholipid classes of the surfactant, proteins, PAF, and cells were measured. High levels of PAF, an increase in neutrophils and proteins, and quantitative as well as qualitative alterations in phospholipids in BAL fluid were observed in ARDS patients compared to the control group. PAF, proteins, and neutrophils were higher in early ARDS than in intermediate or late ARDS. The surfactant pool increased in the early phase and decreased in the intermediate or late phase of the syndrome. The qualitative alterations of surfactant consist of reduced phospholipid content in the surfactant structures with good surface properties; moreover, there was a considerable decrease in the percentage of phosphatidylcholine and phosphatidylglycerol, followed by an increase in phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, and sphingomyelin in all three phases of ARDS compared to the control group. Lysophosphatidylcholine was detectable only in late ARDS.
Conclusion: Total surfactant phospholipids, surfactant components, and inflammatory markers such as PAF, cells, and proteins were affected in patients with ARDS. These factors, undergoing quantitative alterations during the course of ARDS, could have a significant role in the pathogenesis and evolution of ARDS.
Similar articles
-
Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema.Am J Respir Crit Care Med. 1997 Mar;155(3):945-51. doi: 10.1164/ajrccm.155.3.9117030. Am J Respir Crit Care Med. 1997. PMID: 9117030
-
Bronchoalveolar lavage alterations in pulmonary embolism.Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1504-10. doi: 10.1164/ajrccm.158.5.9802036. Am J Respir Crit Care Med. 1998. PMID: 9817700
-
Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome.Crit Care Med. 2003 Mar;31(3):770-5. doi: 10.1097/01.CCM.0000053647.82608.29. Crit Care Med. 2003. PMID: 12626982
-
Surfactant alteration and replacement in acute respiratory distress syndrome.Respir Res. 2001;2(6):353-64. doi: 10.1186/rr86. Epub 2001 Oct 12. Respir Res. 2001. PMID: 11737935 Free PMC article. Review.
-
Age-dependency of surfactant phospholipids and surfactant protein A in bronchoalveolar lavage fluid of children without bronchopulmonary disease.Eur Respir J. 1996 Feb;9(2):328-33. doi: 10.1183/09031936.96.09020328. Eur Respir J. 1996. PMID: 8777972 Review.
Cited by
-
CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.J Clin Invest. 2009 Oct;119(10):2898-913. doi: 10.1172/JCI36498. Epub 2009 Sep 21. J Clin Invest. 2009. PMID: 19770521 Free PMC article.
-
Alveolar type II cell abnormalities and peroxide formation in lungs of rats given IL-1 intratracheally.Inflammation. 2000 Aug;24(4):289-303. doi: 10.1023/a:1007092529261. Inflammation. 2000. PMID: 10850852
-
GPR84 regulates pulmonary inflammation by modulating neutrophil functions.Acta Pharmacol Sin. 2023 Aug;44(8):1665-1675. doi: 10.1038/s41401-023-01080-z. Epub 2023 Apr 4. Acta Pharmacol Sin. 2023. PMID: 37016043 Free PMC article.
-
Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease.Front Pharmacol. 2020 Oct 9;11:572009. doi: 10.3389/fphar.2020.572009. eCollection 2020. Front Pharmacol. 2020. PMID: 33162887 Free PMC article. Review.
-
Enhanced surfactant adsorption via polymer depletion forces: a simple model for reversing surfactant inhibition in acute respiratory distress syndrome.Biophys J. 2007 Jan 1;92(1):3-9. doi: 10.1529/biophysj.106.091157. Epub 2006 Oct 13. Biophys J. 2007. PMID: 17040987 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical